More on SAVA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (5.7 Score)
- Holders

Upcoming Events

- Earnings (5/8/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cassava Sciences (NQ:SAVA)
Delayed: 2.03 -0.01 (0.49%)
Prev. Close $2.04  
Open$2.02 
52 Wk High$ 
52 Wk Low$ 
Day High$2.04 
Day Low$1.96 
P/E N/A  
EPS$ 
Volume676,015 

Friends, Peers and Foes (?): FLNA, GERN SLNO (more...)

Feb 19, 2026 08:15 AM Form 8-K CASSAVA SCIENCES INC For: Feb 19
Feb 19, 2026 08:01 AM Cassava Sciences announces end of DOJ investigation
Feb 19, 2026 08:00 AM Cassava Announces Closure of U.S. Department of Justice Investigation
Jan 21, 2026 02:57 PM Cassava Sciences (SAVA) 28K contracts of January 23 weekly 2.5 calls trade, share price up 9%
Jan 13, 2026 08:01 AM Cassava publishes phase 3 simufilam alzheimer's trial results in journal
Jan 13, 2026 08:00 AM Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
Dec 23, 2025 08:46 AM Form 8-K CASSAVA SCIENCES INC For: Dec 19
Dec 23, 2025 08:02 AM Cassava Sciences agrees to pay $31.25 million to settle class action suit
Dec 23, 2025 08:00 AM Cassava Announces Agreement to Settle Securities Class Action Litigation
Dec 22, 2025 04:10 PM Form 8-K/A CASSAVA SCIENCES INC For: Oct 21
View All Articles

Entities mentioned with SAVA

View All Entities